- Tempus to buy cancer test-maker Personalis for $1.5B<figure><div><img src="https://imgproxy.divecdn.com/_RbdDztrnLOoumxY2iZaJMnVrx0w3LSgoNSRO_aqxDg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjE4Nzk4MTY3LmpwZ…BioPharma Dive · 3d ago↗ source
- UnitedHealth Group lays out progress in AI pushAfter announcing a hefty investment in AI earlier this year, UnitedHealth laid out how it's using the technology across its business in a quarter that landed better than expected. The health insu…Endpoints · 3d ago↗ source
- House lawmakers back trade probe of China biotech, sequencingAt least 10 House lawmakers are backing a US trade panel’s probe of China’s biotech sector and related pricing practices, encouraging future executive action. In a letter sent to Secretary of the…